Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-4

Persistence After Switching From Adalimumab Biosimilar MSB11022 to Adalimumab Biosimilar GP2017 in Patients With Chronic Inflammatory Rheumatic Diseases

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo [...]

Journal of Pharmacy Technology

Open access

Review article

First published 2024

The totality of evidence approach in the development of AVT02 (adalimumab),a biosimilar to Humira

Joseph E. McClellan, Sesselja Ómarsdóttir, Nivedita Roy [...]

Sage Open Chronic Disease

Open access

Research article

First published 2025

Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study

Gabrielle D’Abbundo, Maria Nachury, Alice Wartski [...]

Therapeutic Advances in Gastroenterology

Open access

Case report

First published 2025

Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report

Alessia Lozito, Silvia Baravalle, Gabriele Poddine [...]

Sage Open Medical Case Reports

Open access

Research article

First published 2024

Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients

Hafsah Nabi, Rikke Ibsen, Michael Ibsen [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2021

A propensity score-weighted comparison between adalimumab originator and its biosimilars,ABP501 and SB5,in inflammatory bowel disease: a multicenter Italian study

Brigida Barberio, Linda Cingolani, Cristina Canova [...]

Therapeutic Advances in Gastroenterology

Retricted access

Review article

First published 2022-12

Adalimumab-Adbm: The First Interchangeable Biosimilar for the Treatment of Inflammatory Diseases

Shubha Bhat, Maitri Patel, Kristine Duly [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2024-9

Investigating market trends and access implications for adalimumab following the loss of patent exclusivity: Lessons learned from biosimilar uptake in the U.S. biologic market

Joseph Visingardi, Bryan Sherwood

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Free access

Research article

First published 2018-3

Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Petra Baji, László Gulácsi, Valentin Brodszky [...]

United European Gastroenterology Journal

Open access

Review article

First published 2025

Adalimumab around the world: comparative analysis of products characteristics and patient support systems

Tsz Hong Yiu, Emilia Anderson, Wai Keung Leung [...]

Therapeutic Advances in Gastroenterology

Search results